EBS241108C18000
- 0.05
- 0.000.00%
Emergent BioSolutions Newsroom
Express News | Emergent BioSolutions Appoints DR. Simon Lowry as Chief Medical Officer and Head of Research and Development
Press Release: Emergent BioSolutions Appoints Dr. Simon Lowry as Chief Medical Officer and Head of Research and Development
Earnings Preview: EBS to Report Financial Results Post-market on November 06
First Mpox Case Linked to African Outbreak Reported in U.K.
WHO Expands Emergency Use List For Mpox Diagnostics, Adds Cepheid's Xpert Mpox PCR Test And Roche's Cobas MPXV Assay As PCR-Based Gold Standard Options
Emergent BioSolutions to Release Third Quarter 2024 Financial Results and Conduct Conference Call on November 6, 2024
Reported Earlier, 'New Mpox Variant Detected In Germany: Health Authority' - The Economic Times
Zacks.com Featured Highlights Include Grupo Supervielle, Emergent BioSolutions and Innodata
3 Stocks Poised for Better Returns With New Analyst Coverage
Emergent BioSolutions Inc. (EBS): A Standout Among Best Performing Cheap Stocks in 2024
Emergent BioSolutions Inc (EBS) Q2 2024 Earnings Call Highlights: Navigating Challenges and ...
Emergent BioSolutions Grants CFO Stock for Contributions
What's Going On With Emergent BioSolutions Stock Wednesday?
Emergent Enters New $100 Million Revolving Credit Agreement
Express News | Emergent BioSolutions- as of Sept 30, Has $150 Mln Cash Balance, $100 Mln Undrawn Access
Express News | Emergent BioSolutions Announces Closing of $100 Million Asset-Backed Loan Facility
Press Release: Emergent BioSolutions Announces Closing of $100 Million Asset-Backed Loan Facility
Express News | Emergent BioSolutions Shares Are Trading Higher After CA Gov. Gavin Newsom Signed a Bill Pushing for Narcan in Workplace First Aid Kits
'Newsom Signs Bill Pushing For Narcan In Workplace First Aid Kits' - LA Times
Amazon to Provide Opioid Overdose Drug in Workplace